«New way to unmask melanoma cells to the immune system: Lab studies show promise for a clinical trial aimed at improving
current immune therapies.»
Not exact matches
«
Current therapies in clinical trials are focused on targeting genetic changes in tumors and helping to boost one's
immune system to fight the cancer cells.
Current therapies to treat pathological inflammation generally focus on quieting the overactive
immune response, but in suppressing the
immune system, patients are vulnerable to severe infections arising from other sources.
In the
current trial, two patients experienced an
immune response to the gene
therapy that did not result in safety concerns, and were treated with steroids.
Treatment with the
current standard
therapy, glucocorticoids, can only be used for a short time due to serious side effects leading to fragile bones and suppression of both the
immune system and growth hormone production.
Current therapies for autoimmune disease, such as prednisone and rituximab, suppress large parts of the
immune system, leaving patients vulnerable to potentially fatal opportunistic infections and cancers.
These are skills that we implement for other international trials of gene
therapy for rare genetic diseases of the
immune system, blood, muscle, vision or liver... We will continue the
current study with the objective of providing treatment for patients.»
Current stem cell
therapies have been the standard of care for many cancers, blood and
immune disorders and it is anticipated that new
therapies will be further available as the results of thousands of clinical trials are reported.
Current immunotherapies for colorectal cancer fall into seven broad categories: checkpoint inhibitors and
immune modulators, monoclonal antibodies, therapeutic vaccines, adoptive cell
therapy, oncolytic virus
therapy, adjuvant immunotherapies, and cytokines.
Many of the
current cancer researchers are investigating ways of stimulating the
immune system to recognize the cancer cells specifically and selectively, for example by a vaccine approach (See also «Gene
Therapy» below).
It is not available by itself, and has been shown to cause
immune suppression when given in combination with Canine Distemper (Kirk's
Current Veterinary
Therapy XI, «Canine and Feline Vaccines,» Philips, Schultz), so I would consider not giving it.
Current therapies for IMHA involve suppressing the
immune system, which can cause additional complications.